Aptar Pharma Enters into Exclusive Agreement with Pulmotree to Develop and Promote Kolibri™ Non-Propellant Liquid Inhaler Platform ...

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of ...

BRIDGEWATER, NJ and LONDON, UK / ACCESSWIRE / September 16, 2024 /Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of ...

SupplySide West and Food ingredients North America, is taking place October 28-31, 2024, at the Mandalay Bay,Las Vegas. Take ...

Straumann Dysphagia Index, or SDI, is a patient-reported outcome score that uses a seven-day recall measuring dysphagia (trouble swallowing) severity and frequency.

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer ...

Leading CPG, food and pharmaceutical packaging supplier Carton Service CSI, is expanding their current liquid packaging ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

One woman shares her experience with Major Depressive Disorder and how her three sons have been a powerful source of support ...

HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ... expertise and unique technologies to research, develop, and deliver next-generation therapies. Our approved products in Japan include ...